Key facts
- Notable investors include Peiyang Begonia Fund, Beijing Shangshi Investment Management, Me Too Investment, Tianjin Fengchao Investment.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Poincare
- ·The full record, as it builds
Funding rounds
No funding rounds for Poincare are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Poincare
Manufacturer of analytical instrumentation systems intended for scientific research and industrial diagnostics. The company offers high-resolution time-of-flight mass spectrometry units, quadrupole mass spectrometers, acoustic excitation-mass coupling systems, and integrated spectroscopy and microscopy tools, enabling the life sciences, chemical, and materials research markets to conduct precise molecular analysis, structural imaging, and high-throughput experimental workflows with enhanced sensitivity, modularity, and data fidelity.
- Sector
- Healthcare
- HQ
- Tianjin, China
- Founded
- 2022
- Website
- poincaree.com/
- Ownership
- Privately Held (backing)
Poincare doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Poincare shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Poincare in its N-PORT filings yet. We sweep new filings monthly.